Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra‐High Risk for Psychosis
Early Intervention in Psychiatry · 2026-07 · 20 (7)
DOI: 10.1111/eip.70183 ↗At a glance
Journal article in Early Intervention in Psychiatry, published online on 2026-07-01. Written by Dulari Hakamuwa Lekamlage and 31 co-authors. Institution: Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, Australia. Major MEDLINE topics: Psychotic Disorders, Inflammation, Schizophrenia. 72 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Aims
Negative symptoms are a core component of schizophrenia, affecting up to 60% of individuals with the disorder. They are categorised into primary negative symptoms (PNS), which are intrinsic to the illness, and secondary negative symptoms, which arise from external factors such as depression or medication side effects. They can also be divided into diminished expression and amotivation/anhedonia subtypes. While inflammation has been implicated in schizophrenia and linked to negative symptoms, little is known about whether inflammatory profiles differ between negative symptom subtypes in individuals at Ultra‐High Risk (UHR) for psychosis.
Methods
We conducted a secondary analysis of 147 UHR participants from the Staged Treatment in Early Psychosis (STEP) study to examine whether inflammatory markers (Alpha‐2‐Macroglobulin, IL‐6, CRP, sICAM‐1, sVCAM‐1, and suPAR) differed across negative symptom subgroups, using multinomial and binomial logistic regression models adjusted for age, sex, smoking, and BMI.
Results
Overall, most inflammatory markers were not significantly associated with negative symptom subgroups. However, higher sICAM‐1 levels were asscoiated with lower odds of primary negative symptoms compared with no negative symptoms. Additionally, younger age was associated with increased odds of PNS and amotivation, while smoking was associated with higher odds of secondary negative symptoms compared with no negative symptoms.
Discussion
These findings suggest that inflammation may not broadly distinguish negative symptom subtypes at the UHR stage, although sICAM‐1 may play a role in early illness processes. Limitations include sample ascertainment, potential misclassification of negative symptoms, and the relatively small number of participants with PNS. Future studies with larger samples and longitudinal designs are needed to clarify whether inflammatory changes contribute to the emergence of specific negative symptom subtypes.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, Australia.
- Barwon Health, Geelong, Australia.
- The University of Melbourne, Parkville, Australia.
- University of Birmingham, Birmingham, UK.
- Orygen, Melbourne, Australia.
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
ORCID profiles: Ling Min Amelia Ang, Hok Pan Yuen, Jessica Spark
Cite
APA
Hakamuwa Lekamlage, D., Ang, L. M. A., Sominsky, L., Wood, S. J., McGorry, P. D., Mei, C., Amminger, G. P., Yuen, H. P., Kerr, M., Spark, J., Wallis, N., Polari, A., Baird, S., Buccilli, K., Dempsey, S. A., Ferguson, N., Formica, M., Krcmar, M., Quinn, A. L., …, & Yung, A. R. (2026). Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra‐High Risk for Psychosis. Early Intervention in Psychiatry, 20(7). https://doi.org/10.1111/eip.70183
Vancouver
Hakamuwa Lekamlage D, Ang LMA, Sominsky L, Wood SJ, McGorry PD, Mei C, et al. Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra‐High Risk for Psychosis. Early Intervention in Psychiatry. 2026;20(7). doi:10.1111/eip.70183
BibTeX
@article{HakamuwaLekamlage2026,
author = {Hakamuwa Lekamlage, Dulari and Ang, Ling Min Amelia and Sominsky, Luba and Wood, Stephen J and McGorry, Patrick D and Mei, Cristina and Amminger, G Paul and Yuen, Hok Pan and Kerr, Melissa and Spark, Jessica and Wallis, Nick and Polari, Andrea and Baird, Shelley and Buccilli, Kate and Dempsey, Sarah-Jane A and Ferguson, Natalie and Formica, Melanie and Krcmar, Marija and Quinn, Amelia L and Mebrahtu, Yohannes and Ruslins, Arlan and Street, Rebekah and Wannan, Cassandra and Dixon, Lisa and Carter, Cameron S and Loewy, Rachel and Niendam, Tara A and Shumway, Martha and Nelson, Barnarby and Cotter, David and Susai, Subash and Yung, Alison R},
title = {Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra‐High Risk for Psychosis},
journal = {Early Intervention in Psychiatry},
year = {2026},
volume = {20},
number = {7},
doi = {10.1111/eip.70183}
}
EUVIMED